Stay updated on Aducanumab in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aducanumab in Early Alzheimer's Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated page revision to v3.0.2 from v3.0.1 and removed the 'Back to Top' element. No substantive changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T18:57:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T14:08:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, particularly in the United States, Germany, Japan, and other regions. Additionally, new topics related to Alzheimer's disease and drug safety have been introduced.
    Difference
    14%
    Check dated 2025-08-31T11:42:14.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:33:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T20:21:43.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has been updated to include a disclaimer about the safety and science review of studies listed, and it provides detailed information about a specific clinical trial for Aducanumab in early Alzheimer's Disease, including study objectives, eligibility criteria, and locations.
    Difference
    100%
    Check dated 2025-08-02T15:29:22.000Z thumbnail image

Stay in the know with updates to Aducanumab in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aducanumab in Early Alzheimer's Clinical Trial page.